Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW – Federal Agency Seeks Help in Standardizing THC Dosage

Cannabis has come a long way on its journey to legalization. Just a few years ago, it was illegal at both federal and state level, but now there are numerous states that allow medical or recreational marijuana within their borders. The plant is said to have potent medical properties that make it effective against a wide variety of ailments, but a lot of the evidence is anecdotal.

However, unlike ordinary pharmaceutical drugs, cannabis poses a challenge to researchers looking to provide standardized evidence of its efficacy and side effects. Its medicinal properties can be attributed to a group of unique chemicals called cannabinoids. Present only in the cannabis plant, they interact with the body and produce therapeutic effects. THC, the main psychoactive chemical, is produced in greater quantities than all other cannabinoids.

However, different cannabis varieties produce different levels of the chemicals, and this has made creating standard dosage a nightmare. To alleviate this and push forward research into the plant’s abilities, the National Institute on Drug Abuse (NIDA) is requesting advice from “the scientific community and other interested parties” to help establish a standard. This will ensure consistency among studies into the potential therapeutic benefits and risks of cannabis.

“One hindrance to conducting such research is the lack of a standardized measure of the THC in various cannabis products, making it hard to compare the results of different studies,” stated the agency in its request for information.

Published on Monday, the notice by NIDA admits that the agency knows little about the impact of varying THC potency and that creating a standard unit could help resolve the issue.

“As the diversity of products, potency, and use of cannabis increases, research grows ever more critical to determine both the adverse health effects and therapeutic potential of cannabis and its constituents. Recognizing that a perfect measure may not be attainable at the current time, NIDA still believes that a standard dose would improve measures of outcomes in relation to exposure, and this could inform policy and public health strategies around cannabis use.”

The notice also acknowledges that cannabis contains other chemicals (cannabinoids) that could complicate standardization, as well as the impact of different consumption methods. However, the agency states that “such a unit is critical for conducting rigorous cannabis research,” and it is looking into a five milligram THC dose as the standardized unit.

This comes a month after NIDA Director Nora Volkow discussed the importance of establishing a standardized THC unit. She stated that due to the lack of standardization, studies often show conflicting results. Ultimately, she says, the use of a standard unit dose of THC is an important step for improving our ability to understand the effects of cannabis in the population.”

Analysts are of the view that this request for advice will be seen as good news by sector players like Sugarmade Inc. (OTCQB: SGMD) who want to see some degree of agreement between the scientific community interested in investigating the properties of marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Plus Products Inc.’s (CSE: PLUS) (OTCQX: PLPRF) Distinguished Leadership Team Positions Company for Success

California-based cannabis-products company Plus Products (CSE: PLUS) (OTCQX: PLPRF) is led by a seasoned leadership team that boasts experience in technology, finance and social media. An article discussing the company reads, “The PLUS leadership team spans a wide range of expertise, work experience and industry exposure. After working at Facebook, CEO Jake Heimark co-founded PLUS. Chief strategy officer Craig Heimark lends high-powered finance expertise to the company gained from his experience at UBS and other similar firms. Managing the company’s finances is CFO Jon Paul, who brings more than 25 years of CFO experience to the team. . . . Navigating the constantly changing legal framework is chief risk officer Jennifer Tung, utilizing skills and expertise gained from her time spent at Uber and Facebook. Chief Scientific Officer Ari Mackler brings product knowledge to the company from his role as VP of clinical development at the Wonderful Company, as well as his PhD in neuroendocrinology.”

To view the full article, visit http://cnw.fm/iqu7C

About Plus Products Inc.

PLUS is a hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable — beginning with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, California. For more information, visit the company’s website at www.PlusProducts.com.

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://cnw.fm/PLUS

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Establishing Foothold in China’s Rising CBD Market

ChineseInvestors.com (OTCQB: CIIX) is leveraging its financial expertise to establish itself as a leader in China’s emerging cannabidiol (“CBD”) market. CIIX CEO Warren Wang recently discussed the potential health benefits offered by the company’s CBD-based products in an interview with MoneyTV’s Donald Baillargeon (http://cnw.fm/V4vSv). An article discussing the company reads, “Speaking about CIIX’s current efforts to promote the power of CBD oil, Wang announced that the company entered a deal with Vitamist, an organization that produces premium-quality supplements for health-conscious consumers. ‘Our company is very helpful for Chinese people,’ added Wang. ‘I see tremendous opportunities here within the next three to six months to spread our word, create a community and then sell our products on CBDoil.com.’ . . . With a decades-long successful track record, a robustly diversified business model and increased demand globally for its health and wellness products, CIIX is a compelling investment opportunity for investors seeking to harness the benefits of high-potential companies.”

To view the full article, visit http://cnw.fm/5ejXU

About ChineseInvestors.com Inc.

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company by providing (a) real-time market commentary, analysis and educationally related services in both traditional and simplified Chinese language character sets; (b) advertising and public-relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health-related products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Adapts Operations, Aggressively Reduces Costs While Expanding Product Portfolio

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, on Wednesday announced that, due to market conditions, it is adapting operations and aggressively reducing costs. According to the update, the company has postponed the startup of its Valleyfield facility in order to centralize cultivation operations at Ancaster. The Ontario facility is able to produce larger volumes than initially anticipated, enabling the company to delay Valleyfield cultivation operations while saving costs and capital. “Multiple factors, most particularly the COVID-19 pandemic, are contributing to an environment in which we must be extremely prudent with how we manage our cost structure. These are unprecedented times, and the situation continues to evolve. With the support and unity, I have seen from our employees, partners and stakeholders, I am very confident that TGOD can tackle this challenge and come out much stronger,” TGOD CEO Brian Athaide said in the news release. “We have seen very strong consumer and medical patient feedback from our recent TGOD Infusers launch and are looking forward to having them available in more stores quickly. These along with our upcoming additional 2.0 products are very unique and deliver superior consumer experiences which will help further differentiate and build our TGOD organic brand positioning.”

To view the full press release, visit http://cnw.fm/2MtpR

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) is a premium, certified-organic cannabis company focused on the health and wellness market. Its certified-organic cannabis is grown in living soil, as nature intended. The company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities are built to LEED certification standards, and its products are sold in recyclable packaging. In Canada, TGOD plans to expand its product portfolio by launching a series of next-generation cannabis products such as organic teas, infusers and vapes. Through its European subsidiary, HemPoland, the company also distributes premium hemp-CBD oil in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale. For more information on The Green Organic Dutchman Holdings Ltd., please visit www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://cnw.fm/TGOD

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Honolulu Marijuana Processor to Make Free Hand Sanitizer

When the Coronavirus first appeared in Wuhan, China late last year, no one expected it to have such a worldwide impact. A little more than two months after the virus started ravaging China, it has spread to most continents, infected more than 150,000 and left at least 9,000 people dead. Naturally, most countries are focused on containment efforts, and one of them is calling on people to maintain high levels of hygiene.

The virus spreads through droplets, and one of the best ways to prevent infection is thorough and constant hand washing. However, with massive numbers of people buying hand sanitizers in bulk, shortages were inevitable.

A Hawaiian cannabis company has stepped in to fill this void by providing free hand sanitizers to its clients. Aloha Green Holdings, which does business as Aloha Green Apothecary, has announced that it will “use its cannabis concentrates production line to produce large quantities of hydroalcoholic gels immediately.”

The cannabis firm operates the largest state of the art cannabis manufacturing lab in Hawaii, and it will use these facilities to manufacture free hand sanitizing gel to 329 card holding patients at its two dispensaries. Regulations require patients to have a 329 card to enter a cannabis retail dispensary.

Each patient will be limited to one 50ml bottle per day until Aloha Green ramps up its production. The firm has stated that its intention is to dedicate enough manufacturing lines to produce free hand sanitizers for Oahu’s first responders.

Data from the Department of Health’s Medical Cannabis Registry Program shows that the average age of registered medical cannabis patients in Hawaii is approximately 52. Most of them have underlying medical conditions including cancer, HIV/AIDS, epilepsy, and Multiple Sclerosis, making them especially vulnerable to Covid-19.

“All our locations have a supply of hand sanitizer solution for employee and patient use. We have increased our sanitation procedures. Due to recent reports of hoarding, outages and low supplies in Hawaii, we have decided to manufacture and provide bottles of hand sanitizer free of charge to vulnerable patients who are at increased risk,” says Aloha Green Apoth spokesman TY Cheng.

Aloha Green Apoth CEO James Lee adds that “supporting our local community is a foundational goal for our company. Our cannabis medicines provide essential relief for many patients and we hope patients will continue to feel safe at our dispensaries.”

The firm reminds people that although using a 60%-plus alcohol-based solution is effective, health authorities say that using soap and water is still the most effective method to clean your hands and avoid infection.

Experts say the example set by Aloha Green Apothecary is one that paints the entire cannabis industry, including Champignon Brands Inc. (CSE: SHRM), in good light as sector players are seen as going above and beyond to be helpful to the communities they serve.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – How Marijuana Retailers Can Adapt to the COVID-19 Pandemic

Most of us have never seen or experienced a disease of such epic proportions as the novel Coronavirus. Just a few months after it first appeared, the virus has infected over 150,000 people worldwide and left at least 10,000 dead. According to experts, the virus may end up infecting up to 70% of the world’s population if it continues spreading unabated.

In response, governments all over the world have ordered lockdowns of varying degrees. Since the virus is transmitted through droplets from coughs and sneezes, self-isolation and social distancing are the top preventive measures. This, coupled with constant and thorough hand washing with soap and water or an alcohol-based hand sanitizer is the best way to avoid infection.

Group gatherings are discouraged and all but the most essential businesses have to be closed. For many states, licensed marijuana dispensaries have been lucky to make the cut.

However, with the measures put forth by authorities in response to the pandemic, these businesses will have to adapt to keep both the staff and customers safe. For starters,

Prioritize online bookings. Large gatherings are the virus’ best friend, and people are advised to stay six feet away from each other. This, however, makes shopping in small dispensaries impossible. Online platforms are the best alternative as they allow customers to remotely book their purchase then pop over to the dispensary for a quick pickup.

Curbside pickups are another measure introduced to limit physical contact by states like California, Oregon, Illinois and Michigan. Customers remain in their vehicles, and an employee will bring out your order. Curbside pickups coupled with online bookings will result in a much more efficient and sterile transaction.

Even better, deliver. The best way to prevent congestion at the dispensary is to deliver. While this may require some resources if a delivery system isn’t already in place, it will be a lifesaver during long periods of self-isolation. Customers will want to buy from sellers who deliver right to their doorstep. It completely limits contact or even proximity to large groups, and if the driver takes proper precautions, the entire process will stay as sterile as possible.

While we all hope this pandemic wraps up as soon as possible, it’s more likely the virus will be with us for a while, and the lockdowns even longer. These measures will help marijuana retailers weather the storm that’s sure to come.

It wouldn’t be surprising to learn that cannabis companies like SinglePoint Inc. (OTCQB: SING) are already thinking of ways to adapt to the crisis in order to stay afloat and safeguard customers.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

HempNewsBreaks – MCTC Holdings, Inc. (MCTC) Announces Revolutionary New Class of Hemp Extract Infusion Technologies – EZ Hemp Infusions

MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced a revolutionary new class of hemp extract infusion technologies designed to make hemp infusions simple for both small and large beverage manufacturers. According to the update, the company’s EZ Hemp Infusions product line is based on patented and patent pending 100% water-soluble technology enabling ultra-low doses to hemp extracts and cannabinoids to be utilized. “The days of beverage manufacturers struggling with high dose hemp extracts and cannabinoids infusion technologies are over,” MCTC Holdings CEO Arman Tabatabaei said in the news release. “Manufacturers do not need to add dozens of milligrams of cannabinoids to beverage and struggle with all of the chemicals that are required to stabilize the infusions. With EZ Hemp Infusions, manufacturers can now simply add our 100% water-soluble products to beverages while still being able to print a clean label that contains no chemicals, surfactants or emulsifiers.”

To view the full press release, visit http://cnw.fm/U2mfD

About MCTC Holdings, Inc.

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. For more information, visit the company’s website at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Appoints Ernst & Young 2018 Entrepreneur of the Year in Health Care to Special Advisory Committee

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a health and wellness company specializing in the formulation of a suite of medicinal mushroom health products, as well as novel delivery platforms for the pharmaceutical and nutraceutical industries, today announced the appointment of Dr. Joseph Gabriele, a molecular pharmacologist specializing in signal transduction within the central nervous system, to its Special Advisory Committee. According to the update, Dr. Gabriele, PhD, specializes in the areas of molecular pharmacology, transdermal delivery and formulation chemistry with pharmaceutical, natural molecules and will champion the company’s development and commercialization of rapid onset treatments capable of improving health outcomes. “Dr. Gabriele’s established research credentials, entrepreneurial nature and relentless pursuit of medical innovation represents the desired skill sets that Champignon needs as we accelerate our accession into the psychedelic medicine arena,” Champignon Brands CEO Gareth Birdsall said in the news release. “The appointment of Dr. Gabriele equips us with both a celebrated medical researcher, as well as a seasoned CPG formulation specialist, which will allow for the continued development of our mushroom-infused health products, novel delivery systems and eventual drug discovery initiatives. Champignon Brands is set to emerge as an impact investment that may not only change people’s lives but may also revolutionize the face of medicine as we know it today.”

To view the full press release, visit http://cnw.fm/t88RN

About Champignon Brands Inc.

Champignon Brands Inc. (CSE: SHRM) is a research driven company specializing in the formulation of a suite of medicinal mushrooms health products, as well as novel ketamine, anesthetics and adaptogenic delivery platforms for the nutritional, wellness and alternative medicine industries. Via its vertically integrated alternative medicine product range, Champignon is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes for indications such as depression and Post Traumatic Stress Disorder (“PTSD”), as well as substance and alcohol use disorders. Champignon continues to be inspired by sustainability, as its medicinal mushroom infused SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Webcast Live at March 26 Life Sciences Investor Forum

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, on Tuesday announced that its Chief Executive Officer, Chris Bunka, will present live at LifeSciencesInvestorForum.com on March 26. According to the update, Bunka’s presentation is scheduled to begin at 12:00 PM ET. The live, interactive online event invites investors to ask the company questions in real-time. It is suggested that interested parties pre-register and run the online system check to expedite participation and receive event updates. An archived webcast will be made available after the event for those unable to join live on the day of the conference.

To register and view event details, visit http://cnw.fm/t9NR1

To view the full press release, visit http://cnw.fm/5tmXo

About Lexaria Bioscience

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way API’s enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and can reduce drug costs for orally administered bioactive molecules including nicotine, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and other molecules. Lexaria has licensed DehydraTECH to multiple companies for use in various oral application formats, including to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Coronavirus Outbreak Prompts Nebraska Medical Marijuana Advocates to Halt Campaign

In late 2019, the novel Coronavirus, dubbed COVID-19, first appeared in Wuhan, China, and the country literally ground to a halt. The most hard-hit regions went into lockdowns to prevent the spread of the virus, but it also drastically reduced the county’s manufacturing output. Since China is a known low-cost producer, tons of industries were affected by this disruption in manufacturing, including the cannabis sector.

However, now that the virus has spread to most other continents except Antarctica, supply chain disruptions are only one of many issues we should be worrying about. With all but essential businesses ordered to close and millions of people told to self-isolate, there’s so much more to lose.

In Nebraska, for instance, activists announced on Thursday that they were temporarily suspending signature gathering for a campaign to legalize marijuana in the state. This is just one of the instances where drug policy reform efforts have been hampered by the Coronavirus, with some activists requesting emergency action to allow for alternative means to put the measures on state ballots.

“Thank you to all Nebraskans who have given their support so far to get voter approval of legalized medical cannabis on the ballot box this fall. Your signatures, along with overwhelming citizen support for the measure is going to help make it a reality and bring relief to individuals and communities throughout our entire state,” said Nebraskans for Medical Marijuana in a Facebook post.

Due to current circumstances, it is resigned to the fact that it will have to press pause for now. “Out of an abundance of caution and following the wider recommendations from public health officials, we are going to pause our volunteer and paid signature-gathering efforts within local community gathering places until the state indicates it is responsible to continue.”

“We look forward to the opportunity to get back out there to help Nebraskans create meaningful change for each other, and we wish your loved ones health and peace of mind right now,” the press release concludes.

The proposed amendment would allow doctors to recommend cannabis to patients suffering from predetermined medical conditions. They would also be allowed to possess, purchase and ‘discreetly’ cultivate marijuana for personal use.

The activists have to collect about 130,000 signatures by July 8 for the measure to qualify for the November ballot, although it is not clear how many signatures they have already collected or how long they will continue in-person signature gathering.

Experts believe that while marijuana industry players like MCTC Holdings Inc. (OTC: MCTC) are glad that the campaigners have taken the cautious step of halting signature gathering, it is hoped that the pandemic will end in time to give Nebraskans a chance to vote on the legalization of medical marijuana in the state.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.